<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">MSA</journal-id><journal-title-group><journal-title>Materials Sciences and Applications</journal-title></journal-title-group><issn pub-type="epub">2153-117X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/msa.2019.105031</article-id><article-id pub-id-type="publisher-id">MSA-92692</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Viscoelastic Evaluation of Different Hyaluronic Acid Based Fillers Using Vibrational Optical Coherence Tomography
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Frederick</surname><given-names>H. Silver</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ruchit</surname><given-names>G. Shah</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nikita</surname><given-names>Kelkar</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dominick</surname><given-names>Benedetto</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dale</surname><given-names>DeVore</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Justin</surname><given-names>Cohen</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>DV Consulting, Chelmsford, MA, USA</addr-line></aff><aff id="aff6"><addr-line>Glasgold Group, Princeton, NJ, USA</addr-line></aff><aff id="aff2"><addr-line>Graduate Program in Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ, USA</addr-line></aff><aff id="aff3"><addr-line>OptoVibronex, LLC, Mt. Bethel, Pa, USA</addr-line></aff><aff id="aff4"><addr-line>Center for Advanced Eye Care, Vero Beach, FL, USA</addr-line></aff><aff id="aff1"><addr-line>Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ, USA</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>05</month><year>2019</year></pub-date><volume>10</volume><issue>05</issue><fpage>423</fpage><lpage>431</lpage><history><date date-type="received"><day>18,</day>	<month>April</month>	<year>2019</year></date><date date-type="rev-recd"><day>24,</day>	<month>May</month>	<year>2019</year>	</date><date date-type="accepted"><day>27,</day>	<month>May</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Hylauronic acid (HA) is used as a viscoelastic in Ophthalmology during cataract surgery based on its high viscosity at rest, its ability to shear thin and dissipate energy during phacoemulsification. However, these properties of HA solutions would make them susceptible to migration when used as dermal filler materials. In this study, we apply a new technique termed vibrational optical coherence tomography (VOCT) to compare the physical properties of different HA solutions and fillers used in facial aesthetics. Results presented in this study suggest that HA solutions and HA dermal fillers have markedly different physical properties. HA solutions are highly viscoelastic with high % viscous losses while fillers tend to have lower viscous energy dissipation properties. Clinical observations suggest that the high loss fillers are injected more superficially in the face where tension and internal and external forces are more likely minimized giving tissue of the hands and lips more volume and allowing more natural movement. In contrast, the lower loss gels that are used to lift tissue, generally have a higher G’, and are injected deeper into the face where injection and internal forces are likely to be higher. It is concluded that HA filler gel design can be optimized by use of VOCT to evaluate the % viscous energy loss both 
  <em>in vitro</em> and 
  <em>in vivo</em>.
 
</p></abstract><kwd-group><kwd>Hyaluronic Acid</kwd><kwd> Injectable Filler</kwd><kwd> Dermal Filler</kwd><kwd> Plastic Surgery</kwd><kwd> Cosmetic Surgery</kwd><kwd> Viscoelastic</kwd><kwd> Mechanical Properties</kwd><kwd> Facial Surgery</kwd><kwd> Optical Coherence Tomography</kwd><kwd> Vibrational Optical Coherence Tomography</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hyaluronic acid (HA) also known as hyaluronan, is polysaccharide composed of repeating β-1-4-linked D-glucuronic acid and β-1-3-linked N-acetyl-D-glucosamine disaccharide units [<xref ref-type="bibr" rid="scirp.92692-ref1">1</xref>] . The various names of HA reflect the properties of the molecule under various conditions. At neutral pH, HA exists as a polyelectrolyte with associated cations, frequently as a sodium salt; therefore, the name sodium hyaluronate. The name was later amended to “hyaluronate” in reference to its salt form or “hyaluronan,” a term used to encompass all forms of the molecule [<xref ref-type="bibr" rid="scirp.92692-ref1">1</xref>] .</p><p>HA is found ubiquitously in the ECM of all vertebrate tissues including blood, synovial fluid, vitreous body, pericellular matrix, cytoplasm, and nucleus. Its use as a viscoelastic in Ophthalmology during cataract surgery is based on the molecule’s ability to shear thin and thereby absorb energy during phacoemulsification [<xref ref-type="bibr" rid="scirp.92692-ref2">2</xref>] . This property is a result of the reversible hydrogen bonding that occurs between side chains of the molecule [<xref ref-type="bibr" rid="scirp.92692-ref2">2</xref>] . However, to limit its ability to shear thin and flow under applied stress requires the formation of covalent crosslinks between HA chains.</p><p>Hyaluronic acid (HA) injectable dermal fillers (DFs) have become the most popular agents for soft tissue contouring and volumizing. HA fillers are reported to be characterized by ideal properties such as biocompatibility, biodegradability, and versatility. These filler properties enable HA DFs to dominate and revolutionize the filler market with numerous products differing in HA sourcing, degree of crosslinking, concentration, hardness, cohesiveness, and consistency. The inclusion or lack of inclusion of an anesthetic, indications for use, and longevity of correction are other variables examined in designing DFs [<xref ref-type="bibr" rid="scirp.92692-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.92692-ref4">4</xref>] . However, there are potential complications that can arise from use of these materials [<xref ref-type="bibr" rid="scirp.92692-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.92692-ref6">6</xref>] .</p><p>The rheological and mechanical properties of HA fillers have been reviewed recently [<xref ref-type="bibr" rid="scirp.92692-ref4">4</xref>] . HA fillers have been developed that are both viscous solutions and solution-gel mixtures containing uncrosslinked and crosslinked macromolecules. HA fillers are crosslinked using a number of different crosslinking agents. The HA concentration of fillers ranges from 5.5 to 28 mg/ml, % crosslinking from 0 to 20%, shear elastic modulus from 100 to 1800 Pa, and particle size from 0 to over 1050 micrometers [<xref ref-type="bibr" rid="scirp.92692-ref4">4</xref>] . Observations of the physical properties of HA solutions and gels are important parameters that control the behavior of fillers in clinical use. However, currently, there are no tests available to study the physical properties of fillers both before and after implantation. We have developed a new technique termed vibrational optical coherence tomography (VOCT) that can be used to evaluate HA filler properties both in vitro and in vivo.</p><p>The purpose of this paper is to introduce the use of VOCT to evaluate the physical properties of HA fillers before clinical use. VOCT has been used to evaluate the properties of skin and scar tissue in vivo [<xref ref-type="bibr" rid="scirp.92692-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.92692-ref14">14</xref>] , it can also be used to evaluate the mechanical behavior of skin after filler injections. Characterization of filler viscoelastic properties is needed to determine the desired clinical outcome; how the starting HA filler properties influence the quality of the outcome is a question that needs to be answered.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>VOCT is new technique that measures the resonant frequency and viscous losses of solutions of macromolecules and gels. Unlike measurement of solution viscosity or viscoelasticity using a viscometer, this technique provides measures of both cohesive as well as viscous energy dissipation of materials when a mechanical vibration is applied. This method can be used both in vitro and in vivo unlike a viscometer which can only be used in vitro [<xref ref-type="bibr" rid="scirp.92692-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.92692-ref14">14</xref>] .</p><p>Commercial samples of pure HA with molecular weights of 5 k and 1.8 M were obtained from Lifecore Biomedical, LLC. (Chaska, Mn). Samples of dermal fillers listed in <xref ref-type="table" rid="table1">Table 1</xref> were obtained from Allergan Inc. (Dublin, Ire). A drop containing between 0.1 and 0.2 ml of each sample was placed on a glass slide for examination. The slide was the placed on a rigid frame that had a hole cut out so that the sound was applied to the slide from below. The sample volume did not influence the measurement of resonant frequency. Samples were tested at 22˚C by applying a sinusoidal sound wave from a speaker placed beneath the sample as discussed previously [<xref ref-type="bibr" rid="scirp.92692-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.92692-ref14">14</xref>] . The frame, speaker, and glass slide resonant frequencies were measured in the absence of the samples. Sample weighted displacements were corrected for any resonant frequencies of the speaker and support</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> HA formulations studied using vibrational optical coherence tomography. The % viscous loss is reported at 30 Hz for the HAs studied</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Sample</th><th align="center" valign="middle" >Conc (mg/ml)</th><th align="center" valign="middle" >Resonant Freq (Hz)</th><th align="center" valign="middle" >Viscous Loss (%)</th><th align="center" valign="middle" >Clinical Use</th></tr></thead><tr><td align="center" valign="middle" >Restylane D</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >md/deep</td></tr><tr><td align="center" valign="middle" >Restylane Lft</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >140</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >md/deep</td></tr><tr><td align="center" valign="middle" >Voluma XC</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >md/deep</td></tr><tr><td align="center" valign="middle" >Vollure XC</td><td align="center" valign="middle" >17.5</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >sup/md/deep</td></tr><tr><td align="center" valign="middle" >Restylane L</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >sup/md/deep</td></tr><tr><td align="center" valign="middle" >Juvederm U</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >140 - 180</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >md/sup</td></tr><tr><td align="center" valign="middle" >Restylane S</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >180</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >sup</td></tr><tr><td align="center" valign="middle" >HA (5 k)</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >140</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >N/A</td></tr><tr><td align="center" valign="middle" >HA (1.8 M)</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >220</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >N/A</td></tr></tbody></table></table-wrap><p>Note: the standard deviation of resonant frequency measurements is about 6 Hz while that for % viscosity measurements is about 10% of the % reported. Abbreviations: sp = superficial, md = mid, N/A = not applicable, Freq = resonant frequency, Conc = concentration.</p><p>materials, or from line voltage variations.</p><p>Transverse forces were applied to the sample by positioning an acoustic loudspeaker (Intervox S225RA-40) beneath the sample. A function generator (Agilent) was used to drive the speaker with sinusoidal waveforms at varying amplitudes and frequencies. The resonant frequency was determined as the frequency at which the maximum displacement was observed [<xref ref-type="bibr" rid="scirp.92692-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.92692-ref14">14</xref>] .</p><p>Transverse sample displacement was measured by spectral-domain optical coherence tomography (SD-OCT), a non-contact, interferometric technique [<xref ref-type="bibr" rid="scirp.92692-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.92692-ref14">14</xref>] . The resonant frequency of each sample was initially estimated at a single point by measuring the transverse displacement resulting from sinusoidal driving frequencies ranging from 20 Hz to 500 Hz, in steps of 50 Hz. Once the region where the maximum displacement was identified, smaller steps of 10 Hz were used to more accurately identify the peak frequency and the actual resonant frequency, f<sub>n</sub><sub>.</sub></p><p>Measurement of Elastic and Viscous Behaviors</p><p>The elastic and viscous components of the viscoelastic behavior were obtained from measurements made from the driving frequency peak as described previously [<xref ref-type="bibr" rid="scirp.92692-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.92692-ref14">14</xref>] . The elastic component was obtained from the peak height while the viscous component was obtained by dividing the change in frequency at the half height of the peak (i.e. 3 db down from maximum peak in power spectrum) by the driving frequency. This method is known as the half-height bandwidth method discussed by Paul Macioce (http://www.roush.com/wp-content/uploads/2015/09/Insight.pdf). The viscous loss in percent for each sample was tabulated as a function of the applied sound frequency.</p></sec><sec id="s3"><title>3. Results</title><p>Weighted displacement versus frequency plots for droplets of pure HA with molecular weights 5 k and 1.8 M are shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Major peaks are shown at frequencies of 140 Hz (Mw = 5 k) and 220 Hz (Mw = 1.8 M). The % viscous contribution to the viscoelastic behavior is shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Both pure HA samples, independent of molecular weight, have viscous losses that are about 60% at 30 Hz suggesting that these materials are more viscous than elastic at low frequencies. At frequencies above 200 Hz, these HAs have % viscous losses that approach 10% and behave almost purely elastically. In the absence of crosslinks, HA molecules are highly mobile and do not remain in place when an applied force is exerted on their surfaces.</p><p>Weighted displacement measurements versus frequency for representative dermal fillers listed in <xref ref-type="table" rid="table1">Table 1</xref> are shown in <xref ref-type="fig" rid="fig3">Figure 3</xref> and the % loss behavior for typical dermal fillers examined in this study are shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. The weighted displacement versus resonant frequency curves for all the filler materials exhibit resonant frequencies that center around 150 Hz. The percent loss behaviors of the fillers fall into the two groups the group with losses from about 35% to 40% at 20 Hz (group A) and those with losses of about 25% (group B) at 20 Hz. At high frequencies the % loss decreases to about 5% for all the dermal filler samples studied. At high frequencies all fillers behave almost purely elastic. Note the gel dermal fillers that are used in cosmetic surgery are more elastic (less</p><p>viscous) at high frequencies than are HA liquid solutions.</p><p>The clinical observations of the uses of the different dermal fillers are shown in <xref ref-type="table" rid="table1">Table 1</xref>. It is observed that group B dermal fillers (Restylane Define, Restylane Lyft, Voluma XC), the low loss fillers at low shear rates, are clinically used in the mid to deep areas of the skin whereas group A dermal fillers, the high loss fillers (Juvederm Ultra, Restylane L, Restylane Refine and Restylane Silk, and Vollure XC), are generally used more superficially.</p></sec><sec id="s4"><title>4. Discussion</title><p>HA solutions containing polymeric molecules of different molecular weights are biocompatible natural materials that are viscoelastic and shear thin at high shear rates [<xref ref-type="bibr" rid="scirp.92692-ref3">3</xref>] . While the biocompatibility of these solutions is an important property, the viscoelasticity and liquid-like behavior reflected by the high energy loss at low frequencies limits their ability to remain in place as filler materials. Therefore modifications must be made to solutions of viscoelastics used in Ophthalmology to make these materials function as dermal fillers that do not migrate after injection.</p><p>The most important findings reported in this study, suggest that the viscous behavior of pure HA solutions is much higher than that obtained with any of the dermal filler materials. While pure HA solutions of low and high molecular weights exhibit multiple resonant frequencies, it is clear that uncrosslinked, non-particulate containing HA solutions independent of molecular weight behave as highly viscoelastic liquids. The high % loss at low frequencies indicates that these materials will absorb energy at low shear rates, dissipating energy as needed in cataract surgery. Then at high shear rates they act in an elastic fashion and can be removed from the eye via their cohesive forces as a bolus of material. In contrast they make poor fillers since they will dissipate energy by migrating in an irreversible fashion when an external force is applied to tissue.</p><p>In contrast, HA dermal filler materials are required to remain in place after injection even after the application of external forces that occur during sleeping or other daily activities. The addition of crosslinks and resulting gel particles decreases the shear thinning of HA and reduces the energy losses and viscoelasticity of the filler materials. HA dermal fillers can be classified into two groups, based on the results reported in this paper: the groups are characterized by differences in the viscous losses at low strain rates. The high loss group includes Juvederm Ultra, Restylane L, Vollure XC, Restylane Silk. This group had % viscous losses in the 35% - 40% range while the low loss group Voluma XC, Restylane Define, Restylane Lyft and had viscous losses of about 25%.</p><p>Clinically, the high loss “thinner” gel group has been observed to be more appropriate for superficial indications to remove fine wrinkles and for lip enhancement. Tissue tension due to forces from collagen fibers along Langer’s lines and external forces are more likely to be minimized in these regions of the face. In contrast, the lower loss “thicker” DF gels that are used to lift tissue, generally have a higher G’, and are injected deeper into the face where volume induced internal forces are likely to be higher. Optimization in the physical properties of the injectable dermal fillers evaluated in this study would be difficult to achieve without a multifactorial design that considers concentration, particle size, and degree of crosslinking in a single study. Differences in these factors make analysis of the optimization of filler composition and properties difficult to achieve.</p></sec><sec id="s5"><title>5. Conclusions</title><p>HA solutions containing polymeric molecules of different molecular weights are biocompatible natural materials that are viscoelastic and shear thin at high shear rates. While pure HA solutions of low and high molecular weights exhibit multiple resonant frequencies, it is clear that uncrosslinked non-particulate containing HA solutions independent of molecular weight flow easily under applied stress that makes them poor filler materials to use for tissue augmentation. The addition of crosslinks and gel particles in HA filler materials decreases the shear thinning of HA and reduces the energy losses and viscoelasticity.</p><p>Our results suggest that HA fillers can be categorized into two groups. Clinically, the high loss group has been observed to be used more superficially in the face where tissue tension and internal and external forces are more likely minimized. In contrast, the lower loss gels that are used to lift tissue, generally have a higher G’, and are injected deeper into the face where injection and internal forces are likely to be higher. Unlike HA dermal filler gels, HA solutions used in cataract surgery exhibit high % viscous losses and are not useful in aesthetic surgery due to their tendency to migrate under applied internal and external forces. Future work will evaluate the % viscous losses of dermal filler materials after injection in vivo.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Silver, F.H., Shah, R.G., Kelkar, N., Benedetto, D., DeVore, D. and Cohen, J. (2019) Viscoelastic Evaluation of Different Hyaluronic Acid Based Fillers Using Vibrational Optical Coherence Tomography. Materials Sciences and Applications, 10, 423-431. https://doi.org/10.4236/msa.2019.105031</p></sec></body><back><ref-list><title>References</title><ref id="scirp.92692-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Silver, F.H., Shah, R.G., Benedetto, D., Dulur, A. and Kirn, T. (2019) Virtual Biopsy and Physical Characterization of Tissues, Biofilms, Implants and Viscoelastic Liquids Using Vibrational Optical Coherence Tomography. World Journal Mechanics, 9, 1-6. https://doi.org/10.4236/wjm.2019.91001</mixed-citation></ref><ref id="scirp.92692-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Silver, F.H. and Silver, L.L. (2018) Use of Vibrational Optical Coherence Tomography in Dermatology. Archives of Dermatology and Skin Care, 1, 3-8.</mixed-citation></ref><ref id="scirp.92692-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Silver, F.H. and Shah, R.G. (2018) Mechanical Spectroscopy and Imaging of Skin Components in Vivo: Assignment of the Observed Moduli. Skin Research and Technology, 25. https://doi.org/10.1111/srt.12594</mixed-citation></ref><ref id="scirp.92692-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Silver, F.H., DeVore, D. and Shah, R. (2017) Biochemical, Biophysical and Mechanical Characterization of Decellularized Dermal Implants. Material Sciences and Applications, 8, 873-888. https://doi.org/10.4236/msa.2017.812064</mixed-citation></ref><ref id="scirp.92692-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Shah, R.G., DeVore, D. and Silver, F.H. (2018). Biomechanical Analysis of Decellularized Dermis and Skin: Initial in Vivo Observations Using OCT and Vibrational Analysis. JJournal of Biomedical Materials Research Part A, 106. https://doi.org/10.1002/jbm.a.36344</mixed-citation></ref><ref id="scirp.92692-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Silver, F.H. and Silver, L.L. (2017) Non-Invasive Viscoelastic Behavior of Human Skin and Decellularized Dermis Using Vibrational OCT. Dermatology Clinics &amp; Research, 3, 174-179.</mixed-citation></ref><ref id="scirp.92692-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Shah, R., Pierce, M.C. and Silver, F.H. (2017) A Method for Non-Destructive Mechanical Testing of Tissues and Implants. Journal of Biomedical Materials Research Part A, 105, 5-22. https://doi.org/10.1002/jbm.a.35859</mixed-citation></ref><ref id="scirp.92692-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Shah, R., DeVore, D. and Pierce, M.G. (2016) Morphomechanics of Dermis: A Method for Non-Destructive Testing and Collagenous Tissues. Skin Research and Technology, 23.</mixed-citation></ref><ref id="scirp.92692-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Vedamurthy, M. (2018) Beware What You Inject: Complications of Injectables-Dermal Fillers. Journal of Cutaneous and Aesthetic Surgery, 11, 60-66. https://doi.org/10.4103/JCAS.JCAS_68_18</mixed-citation></ref><ref id="scirp.92692-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Urdiales-Gálvez, F., Escoda Delgado, N., Figueiredo, V., Lajo-Plaza, J.V., Mira, M., Mar Mira, Ortíz-Martí, F., del Rio-Reyes, R., Romero-á lvarez, N., Ruiz del Cueto, S., Martía A. Segurado, M.A. and Villanueva Rebenaque, C. (2017) Preventing the Complications Associated with the Use of Dermal Fillers in Facial Aesthetic Procedures: An Expert Group Consensus Report. Aesthetic Plastic Surgery, 41, 667-677. https://doi.org/10.1007/s00266-017-0798-y</mixed-citation></ref><ref id="scirp.92692-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Greene, J.J. and Sidle, D.M. (2015) The Hyaluronic Acid Fillers Current Understanding of the Tissue Device Interface. Facial Plastic Surgery Clinics of North America, 23, 423-432. https://doi.org/10.1016/j.fsc.2015.07.002</mixed-citation></ref><ref id="scirp.92692-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Fallacara, A., Manfredini, S., Durini, E. and Vertuani, S. (2017) Hyaluronic Acid Fillers in Soft Tissue Regeneration. Facial Plastics Surgery, 33, 87-96. https://doi.org/10.1055/s-0036-1597685</mixed-citation></ref><ref id="scirp.92692-ref13"><label>13</label><mixed-citation publication-type="book" xlink:type="simple">Silver, F.H. and Benedetto, D. (1996) Polysaccharides Used in Ophthalmology. In: Dumitriu, S., Ed., Polysaccharides Used in Medicinal Applications, Marcel Dekker Inc., New York, 689-703.</mixed-citation></ref><ref id="scirp.92692-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Dicker, K.T., Gurski, L.A., Pradhan-Bhat, S., Witt, R.L., Farach-Carson, M.C. and Jia, X. (2014) Hyaluronan: A Simple Polysaccharide with Diverse Biological Functions. Acta Biomaterialia, 10, 1558-1570. https://doi.org/10.1016/j.actbio.2013.12.019</mixed-citation></ref></ref-list></back></article>